Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Operating Margin (2009 - 2026)

Updated

Dr Reddys Laboratories' Operating Margin was 14.63% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 5.26 percentage points from 19.89% a year earlier but up 9.94 percentage points from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Operating Margin (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Dr Reddys Laboratories' Operating Margin was 9.74% through Sep 30, 2026, down 11.12 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it came in at 15.06%, down 7.04 percentage points from FY2025.

  • Operating Margin shows a five-year change of +2.26 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Operating Margin was 22.09% in FY2025 (-2.17 pp), 24.27% in FY2024 (+1.04 pp), 23.23% in FY2023 (+9.46 pp) and 13.77% in FY2022 (+0.97 pp).
  • Quarterly Operating Margin has moved between 1.76% (fiscal Q4 2026) and 26.14% (fiscal Q4 2023) over five years.
  • Compared with a year earlier, Operating Margin has declined for 11 straight quarters, with an average year-over-year change of -6.61 percentage points over the last eight quarters.
  • The best year-over-year quarter for Operating Margin over five years was fiscal Q4 2023 (a gain of 23.35 percentage points); the worst was fiscal Q4 2026 (a drop of 18.98 percentage points).
  • Per Business Quant data, RDY's Operating Margin in the three fiscal quarters before Q2 2027 was 4.69% (Q1 2027), 1.76% (Q4 2026) and 16.32% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 52.42%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 24.35%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 36.01%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 30.89%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 29.12%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 35.79%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 41.71%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 32.98%
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 14.63%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 14.63%
Jun 30, 2026 4.69%
Mar 31, 2026 1.76%
Dec 31, 2025 16.32%
Sep 30, 2025 19.89%
Jun 30, 2025 20.45%
Mar 31, 2025 20.75%
Dec 31, 2024 22.40%
Sep 30, 2024 21.89%
Jun 30, 2024 23.36%
Mar 31, 2024 21.12%
Dec 31, 2023 23.93%
Sep 30, 2023 25.97%
Jun 30, 2023 25.97%
Mar 31, 2023 26.14%
Dec 31, 2022 19.69%
Sep 30, 2022 24.27%
Jun 30, 2022 25.59%
Mar 31, 2022 2.79%
Dec 31, 2021 10.46%
API Access

Dr Reddys Laboratories Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY